The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and ...

The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a ...

Viral membrane proteins are the proteins of choice in vaccines but are difficult to produce quickly and reliably for use in vaccines, limiting rapid response during emerging outbreaks. Researchers ...

Live attenuated vaccines mimic natural infections, providing strong immunity but require refrigeration and caution for immunocompromised individuals. Subunit vaccines offer targeted immunity without ...